ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Accumulus Synergy and Veeva Systems Partner to Advance Regulatory Transformation and Connectivity

BURLINGAME, Calif., June 04, 2025 (GLOBE NEWSWIRE) -- Today, Accumulus Synergy (“Accumulus”) announced a strategic partnership with Veeva Systems (“Veeva”) focused on enabling connectivity to help the life sciences industry more effectively exchange regulated information with national regulatory authorities (NRAs) around the world. The partnership aims to empower customers with the tools needed to meet today’s regulatory interoperability demands while maintaining the flexibility to adapt to the evolving regulatory technology landscape.

“Our partnership with Veeva is an important step forward in enabling our collective customers to maximize the benefit of the two technologies - Accumulus' single dossier in the cloud and Veeva's comprehensive Regulatory Information Management (RIM) platform,” said Francisco Nogueira, CEO of Accumulus. “At Accumulus, we have seen tremendous cycle time improvements driven by our platform. Through this partnership, we’re poised to significantly increase organizational efficiency for our customers by providing connectivity between Veeva RIM and the Accumulus platform.”

The partnership is designed to bridge current requirements and emerging needs, supporting near-term connectivity while aligning with global efforts to modernize regulatory technology. It will enable life sciences organizations to seamlessly connect systems across borders and platforms without being locked into legacy approaches.

“Our customers are eager to find innovative solutions to drive efficiencies in NRA interactions and review cycles,” said Marc Gabriel, Vice President, Regulatory at Veeva. “We look forward to working with Accumulus to build connections to advance the industry.”

The Accumulus-Veeva partnership represents a shared vision for an ecosystem where collaboration drives progress and sponsors are empowered with meaningful solutions. Accumulus and Veeva are positioning the industry for sustainable innovation by bridging Veeva RIM and NRAs in the cloud.

About Accumulus Synergy
Accumulus Synergy is a leading cloud technology provider reimagining how life sciences organizations and national regulatory authorities work together to accelerate cycle times from drug discovery through global availability. Accumulus is working with key stakeholders in the life sciences – regulatory ecosystem to build and sustain a platform that aims to meet regulatory, cybersecurity, and privacy requirements spanning clinical, safety, chemistry, and manufacturing and regulatory exchanges and submissions. Accumulus Synergy members include leading global pharmaceutical companies.

Media Contact
E: allison.mari@accumulus.org
P: 540-907-6053


Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  234.42
+0.00 (0.00%)
AAPL  286.19
+0.00 (0.00%)
AMD  215.24
+0.00 (0.00%)
BAC  53.19
+0.00 (0.00%)
GOOG  316.02
+0.00 (0.00%)
META  647.10
+0.00 (0.00%)
MSFT  490.00
+0.00 (0.00%)
NVDA  181.46
+0.00 (0.00%)
ORCL  201.10
+0.00 (0.00%)
TSLA  429.24
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.